Multidrug resistance of testis cancers: The study of clinical relevance of P-glycoprotein expression

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3447-3452

  Eid, H ^a   Bodrogi, I ^a   Csokay B ^a   Olah E ^a   Bak, M ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Clinical correlation; P glycoprotein immunohistochemistry; Testis cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GENE PRODUCT; GLYCOPROTEIN P; IFOSFAMIDE; VINBLASTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GERM CELL TUMOR; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEMINOMA; TESTIS CANCER; TUMOR GROWTH; TUMOR RESISTANCE;

ADOLESCENT; ADULT; AGED; CARCINOMA, EMBRYONAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENDODERMAL SINUS TUMOR; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; P-GLYCOPROTEIN; SEMINOMA; TERATOMA; TESTICULAR NEOPLASMS;

EID: 0030519428     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gottesman M, Pastan I: Biochemistry of multidrug resistance mediated by the multi-drug transporter. Annu Rev Biochem 62: 385-427, 1993.
2. Katagari A, Tomita Y, Nishiuama T, Kimura M, Sato S: Immunohistochemichal detection of P-glycoprotein and GSTP-1 in testis cancer. Br J Cancer 68: 125-129, 1993.
3. International Union Against Cancer (UICC): TNM classification of malignant tumours, 4th, Fully rev. ed. New York: Springer-Verlag 1987.
4. Javadpour N: The role of biologic tumor markers in testicular cancer. Cancer 45: (Suppl) 1755-1761, 1980.
5. Mostofi FK: Testicular tumors. Epidemiology, etiologic and pathologic features. Cancer. (Philad) 32: 1186-1201, 1973.
6. Cordell JI, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulsard KA, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of anti-alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229, 1984.
7. Williams SD, Einhorn LH, Greco AF, Oldham R, Fletcher R:VP-16213 salvage therapy for refractory germinal neoplasms Cancer 46: 2154-2158, 1980.
8. Schmoll HJ: The role of Ifosfamide in testicular cancer. Proc. 13th International Cancer Congress, Seattle, 626, Ahstr,3580, 1982.
9. Peckham MJ, Barret KH, Liew KH, Horvich A, Robinson B, Dobbs HJ, McElwain TJ, Hendry Wfl: Treatment of metastatic germ-cell testicular tumours with Bleomycin, Etoposide and Cisplatin (BEP).Br J Cancer 47: 613-619, 1983.
10. Monfardini S, Brunner K, Crowther D, Olive D, MacDonald J, Eckhardt S, Whitehouse J, Mattern J, Volm M, Reed D: Manual of Cancer Chemotherapy, Third edition, UICC Technical Report Series 56, Geneva 19.
11. Cordon Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed M.R. Bertion JR: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Pros Natl Acad Sci USA 86: 695-698, 1989.
12. Bak M, Efferth T, Mickisch G: Detection of drug resistance and P-glycoprotein in human renal cell carcinomas. Eur Urol 17: 72- 1990.
13. Ramani P and Dewchand H: Expression of mdr1/P-glycoprotein and pl lo in neuroblastoma. J Pathol 175: 13-19, 1995.
14. Peckham MJ: An appraisal of the role of radiation therapy in the managment of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy. Cancer Treat Rep 63: 1653-1658, 1979.
15. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Klusens LF, Grogan TM, Saclarids TJ, Roninson IB, Coons JS: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720-2726, 1991.
16. Bradley G, Sharma R, Rajalakshmi S, Ling U: P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 52: 5154-5161, 1992.